PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3905684

[Decrease of paraprotein secretion despite progressive tumor cell proliferation by cytostatic drug therapy of plasmacytoma].

K H Zurborn·I Sondermann·W L Gross
View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Antineoplastic Combined Chemotherapy ProtocolsBone and BonesCyclophosphamideHumansImmunoglobulinsMaleMiddle AgedMultiple MyelomaNandroloneNandrolone DecanoateParaproteinemiasPrednisoneRadionuclide ImagingVincristineCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K H Zurborn, I Sondermann, W L Gross. 1985. [Decrease of paraprotein secretion despite progressive tumor cell proliferation by cytostatic drug therapy of plasmacytoma].. https://pubmed.ncbi.nlm.nih.gov/3905684/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Adjuvant therapy for primary breast cancer in a female patient affected by autoimmune liver disease: does it cure breast cancer and primary biliary cirrhosis?

Polychemotherapy (CMF or CMF-like regimens) is the treatment of choice in premenopausal breast cancer patients with 1-3 positive nodes. In clinical practice, patients with abnormal biochemical tests of liver function are usually excluded from this potentially curative methotrexate-containing regimen in order to avoid worsening of hepatic damage. On the other hand, recent reports have shown a beneficial effect of methotrexate in a particular autoimmune liver disease such as primary biliary cirrhosis. We discuss the case of a female patient with breast cancer and primary biliary cirrhosis whose biochemical tests of liver function and the titer of antimitochondrial antibody persistently improved after treatment with 3 cycles of CMF. In conclusion, we suggest that the CMF regimen is potentially useful in patients with breast cancer and primary biliary cirrhosis.

Antineoplastic Combined Chemotherapy Protocols↗